Use of menopausal hormone therapy is associated with an increased rate of dementia and Alzheimer’s disease, suggests a large Danish study published by The BMJ today.
Only a third of employers and health plans cover GLP-1 drugs for weight loss, report says
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Companies still aren’ … Sign up to